masthead-iceburg4.jpg

PocketECG® Blog. Remote Arrhythmia Monitoring Market

Marek Dziubinski

Ph.D. scientist, innovator
Find me on:

Recent Posts

Much Ado about Nothing? Five Things to Know about the USPSTF Report on ECG Screening for AF

Sep 17, 2018 9:10:46 AM / by Marek Dziubinski posted in Market digest

 

Many cardiologists were no doubt surprised to read accounts of the recent U.S. Preventive Services Task Force (USPSTF) Evidence Report on ECG screening for atrial fibrillation, which included this headline from the American Academy of Family Physicians: “USPSTF: Evidence Lacking on Screening for AFib with ECG”. Without knowing the specifics of the study, it would be easy to misinterpret this to mean that ECG screening does not effectively detect incidents of atrial fibrillation (AF).

Read More

PocketECG Cardiac Rehabilitation System: Now Cleared by the FDA and on Preview at AACVPR

Sep 6, 2018 4:24:47 AM / by Marek Dziubinski posted in Market news, Physicians, Cardiologists

This month cardiovascular and pulmonary rehabilitation specialists from around the world will gather for AACVPR 2018, to exchange best practices and ideas, and experience firsthand the latest technology designed to advance and strengthen outcomes for heart patients.

Read More

For Meaningful Stroke Prevention, You Can’t Afford to Miss a Beat.

Aug 9, 2018 9:26:00 AM / by Marek Dziubinski posted in Physicians, stroke

Effective arrhythmia monitoring to reduce stroke risk

Detecting atrial fibrillation (AF) events, particularly paroxysmal AF, is especially challenging. Asymptomatic and episodic, PAF often goes undetected increasing the likelihood of cryptogenic stroke and TIA. But even more difficult, is capturing and correctly interpreting all of the heart rhythm data needed to accurately assess a patient’s risk for stroke.

Read More

HRS Study: Online, Full Disclosure ECG Monitoring Outperforms Offline Holter and Patches

May 8, 2018 5:06:00 PM / by Marek Dziubinski posted in Market news, Market digest, HRS

Though the precise cause of ischemic stroke cannot be determined in 20 to 40% of cases (cryptogenic stroke), paroxysmal atrial fibrillation (PAF) is often a major contributing factor.  A wide variety of methods are used to detect PAF with monitoring durations that typically range from 1-30 days. If left untreated, PAF can lead to heart-related complications, including blood clots, stroke, and heart failure.

Read More

Cardiac Monitoring for AF: How Long is Long Enough?

Apr 30, 2018 9:10:00 AM / by Marek Dziubinski posted in Market digest, HRS

New Data on the Relationship Between Monitoring Duration and Diagnostic Yield in Patients with Paroxysmal Atrial Fibrillation Will be Presented at HRS

What is the optimal duration of cardiac monitoring for detection of atrial fibrillation (AF)?  

What monitoring methods will result in higher diagnostic yields?

Will continuous monitoring for extended lengths of time improve detection of paroxysmal AF (PAF), which occurs intermittently and accounts for an estimated 25% - 60% of AF events?

Read More